PEG Preservation Solution for Stem Cell Cryostability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing stem cell preservation methods, particularly in cryopreservation, suffer from decreased cell viability over time and are susceptible to contamination, with current solutions failing to maintain high cell stability and functionality during transportation and storage.

Innovation Solution

An aqueous solution comprising polyethylene glycol (PEG) with a molecular weight of about 35000 Da is used as an extracellular agent, optionally with dimethyl sulfoxide (DMSO) for cryopreservation, to enhance stem cell preservation and viability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If hypothermic storage (0-5°C) is used for stem cell preservation, then cell viability is maintained in short term, but storage duration is limited and long term preservation requires freezing

Engineering Contradiction:
Improvestorage durationVSAvoidcell viability
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the storage solution by incorporating specific concentrations of DMSO (5-20%), PEG 35kDa (0.01-5 mmol/l), and other protective agents. This chemical parameter modification enables the solution to protect cells during both hypothermic and cryopreservation conditions, extending storage duration without compromising cell viability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite preservation solution containing multiple protective agents working synergistically: DMSO as cryoprotectant, PEG 35kDa for membrane stabilization, human serum albumin for protein protection, and various buffers and nutrients. This composite formulation addresses both short-term hypothermic and long-term cryopreservation needs simultaneously.

Inventive Principle:
Principle #40Composite materials

2Duration of action of stationary object

If cryopreservation with DMSO is used for long term storage, then storage duration is extended, but cell death from intracellular ice formation and chemo-osmotic stress increases

Engineering Contradiction:
Improvestorage durationVSAvoidcell death from freezing
Core Design Contradiction:
Duration of action of stationary objectVSObject-affected harmful factors

Solution Approach 1:

The patent introduces PEG 35kDa as an intermediary substance that mediates between the cryoprotectant DMSO and the cell membrane. PEG stabilizes membranes during freezing stress and reduces chemo-osmotic shock, thereby protecting cells from ice formation damage while maintaining the cryopreservation capability for long-term storage.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies multiple protective agents beforehand to cushion cells against freezing damage. The combination of DMSO, PEG, albumin, and other agents creates a protective environment that prevents intracellular ice formation and reduces chemo-osmotic stress before freezing occurs, thereby reducing cell death during cryopreservation.

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

3Quantity of substance

If conventional preservation solutions are used, then manufacturing cost is controlled, but cell stability and functionality during transportation deteriorate

Engineering Contradiction:
Improvecell stabilityVSAvoidmanufacturing cost
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent optimizes the concentration parameters of each component to achieve the right balance between cell protection and cost. By carefully selecting concentrations (e.g., DMSO 5-20%, PEG 0.01-5 mmol/l, albumin 1-10%), the formulation achieves high cell stability during transportation while controlling manufacturing costs through efficient use of expensive protective agents.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution maintains high stem cell viability and functionality, allowing broader temperature ranges during transportation and prolonged storage, making cells more resistant to varying conditions.

Implementation Method 1

an aqueous solution comprising polyethylene glycol (PEG) having a molecular weight about 35000 Da as an extracellular agent for preserving stem cells

Methodology Applied
Scientific EffectCryoprotection:

Implementation Method 2

it is necessary to freeze the preserved materials in temperature range between their freezing temperature and temperature of liquid nitrogen (−196° C.)

Methodology Applied
Scientific EffectFreezing point depression:

Implementation Method 3

Cryoprotectants, for examples dimethyl sulfoxide (DMSO), are used for that purpose. In order to eliminate the cell death caused by freezing mainly due to the intracellular ice formation and chemo-osmotic stress

Methodology Applied
Scientific EffectCryoprotection:

Implementation Method 4

Cells immersed in such solutions in temperature of 4° C. remain in a state called sustained hypothermia

Methodology Applied
Scientific EffectHypothermia:

Data Source

PatentUS12495793B2Preservation of stem cells
Publication Date: 2025.12.16 CARNAMEDICA SP ZOO
  • US12495793B2 patent drawing
  • US12495793B2 patent drawing
  • US12495793B2 patent drawing

AI summary

The invention relates to a field of stem cell preservation and in particular to use of an aqueous solution comprising polyethylene glycol (PEG) having a molecular weight about 35000 Da as an extracellular agent for preserving stem cells.